🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yi Shi

Huzhou University

ORCID: 0000-0002-3068-2044

Also affiliated with Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial”.

Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial

The Lancet Oncology(2021)10.1016/s1470-2045(21)00004-8

N/A

5.8DataRank · unranked

418 citations

Maha Hussain, Jürgen E. Gschwend, Peter Albers, Stéphane Oudard, Daniel Castellano +21 more

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer

Frontiers in Pharmacology(2020)10.3389/fphar.2020.574667

N/A

0DataRank · unranked

348 citations

David J. Riese, Jianzhong Shen, Yi Shi

A purinergic mechanism underlying metformin regulation of hyperglycemia

iScience(2023)10.1016/j.isci.2023.106898

N/A

0DataRank · unranked

6 citations

Qianman Peng, Yi Shi, Shenqi Qian, Jianzhong Shen, Jared I. Senfeld

218 Development of a microfluidic system for studying the wound healing process in lung submucosal gland epithelial cells isolated from people with F508del cystic fibrosis

Journal of Cystic Fibrosis(2023)10.1016/s1569-1993(23)01148-7

N/A

0DataRank · unranked

0 citations

H. Kim, Kathryn A. Wikenheiser‐Brokamp, Anjaparavanda P. Naren, Kyu Shik Mun, Yi Shi